TNF and Insulin resistance: The use of TZDs in the treatment of T2D improves insulin resistance by increasing GLUT-4 levels and decreasing the levels of cytokines that induce insulin resistance, such as TNF-α and IL-6 [15] by antagonizing the activity of proinflammatory transcription factors [2].